Dog Hip Dysplasia: Symptoms, Diagnosis, and Treatment Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Hip dysplasia is a developmental orthopedic disease in which the coxofemoral joint (ball-and-socket hip joint) develops abnormally: the acetabulum (socket) is too shallow, the femoral head is not perfectly spherical, or the joint capsule and supporting ligaments are lax during skeletal development, allowing the femoral head to subluxate (partially dislocate) rather than seat firmly in the acetabulum; this abnormal motion during growth causes cartilage wear, bone remodeling, and eventually osteoarthritis (OA); hip dysplasia is the most common cause of rear limb lameness in large and giant breed dogs and the most commonly diagnosed orthopedic disease in dogs overall.
- Hip dysplasia has a strong heritable component: it is a polygenic trait (multiple genes contribute) influenced by environmental factors, particularly rapid growth, high-calorie diets in puppyhood, and excessive high-impact exercise during skeletal development; heritability estimates range from 0.2 to 0.6 depending on the breed, meaning 20 to 60 percent of the variation in hip joint quality between individual dogs can be explained by genetics; responsible breeding using radiographic screening of breeding stock (OFA or PennHIP) has significantly reduced the prevalence of severe hip dysplasia in screened populations of German Shepherd Dogs, Labrador Retrievers, and Golden Retrievers over the past 40 years.
- Two major hip screening programs exist: the Orthopedic Foundation for Animals (OFA) evaluates hip conformation on a ventrodorsal extended hip radiograph taken at 24 months of age and assigns grades of Excellent, Good, Fair (normal range), Borderline, Mild, Moderate, and Severe dysplasia; only dogs graded Normal (Excellent/Good/Fair) should be used for breeding; PennHIP (University of Pennsylvania Hip Improvement Program) uses a distraction radiograph technique to measure the distraction index (DI), which quantifies passive hip laxity (the ratio of femoral head subluxation distance to femoral head radius); a DI of 0 indicates no laxity (perfectly congruent); a DI above 0.3 to 0.5 is associated with increasing risk of osteoarthritis development; PennHIP can be performed as early as 16 weeks of age, making it more actionable for early intervention decisions than OFA which requires 24 months.
- The single most impactful non-surgical intervention for hip dysplasia at any age is maintaining an optimal body weight; every excess kilogram of body weight places roughly 3 to 4 kilograms of additional force across hip and stifle joints during normal ambulation; a landmark study in Labrador Retrievers (Kealy et al., JAVMA 2002) demonstrated that dogs maintained at 25 percent below free-fed body weight developed radiographic hip osteoarthritis significantly later and lived nearly 2 years longer on average than their heavier paired siblings; weight management combined with regular moderate low-impact exercise (leash walks, swimming, controlled on-leash activity) is the foundation of medical management for hip dysplasia.
- Surgical options for hip dysplasia span three categories: preventive surgery in young dogs (juvenile pubic symphysiodesis, JPS, performed before 20 weeks of age; triple or double pelvic osteotomy, TPO/DPO, performed in skeletally immature dogs under 10 to 12 months without severe existing OA), salvage surgery (femoral head and neck ostectomy, FHO, which removes the femoral head and allows a fibrous false joint to form; appropriate for small to medium dogs and as a last resort in larger dogs), and total hip replacement (THR, the definitive treatment offering near-normal joint function; available as cemented or cementless systems; best outcomes in dogs over 40 to 45 lbs with no active infection and adequate bone quality); THR in appropriately selected dogs returns 90 to 95 percent to normal or near-normal function.
- Polysulfated glycosaminoglycan (Adequan, brand name; active ingredient: polysulfated glycosaminoglycan PSGAG) is an injectable disease-modifying osteoarthritis agent (DMOA) that works by inhibiting degradative enzymes in cartilage (metalloproteases, hyaluronidase), stimulating synoviocytes to produce hyaluronic acid, and providing substrate for cartilage proteoglycan synthesis; the standard induction protocol is 2 mg/kg intramuscularly twice weekly for 4 weeks (8 injections), followed by monthly maintenance; it is one of the most evidence-supported disease-modifying treatments for canine OA and is frequently combined with NSAIDs, fish oil, and physical rehabilitation for comprehensive hip dysplasia management.
The 8-month-old German Shepherd mix had been bunny-hopping up the stairs for two weeks. The owner thought he was just being playful, that exaggerated two-legged rear gait puppies sometimes do. At the orthopedic appointment, the veterinarian performed an Ortolani test: with the dog in lateral recumbency and the hip flexed, gentle abduction produced a palpable and audible “clunk” as the subluxated femoral head reduced back into the acetabulum. Bilateral. Radiographs confirmed bilateral hip dysplasia with shallow acetabula and rounding of both femoral heads. At 8 months, the dog had not yet developed significant osteoarthritis, but without intervention, he would. The question was not whether this dog’s hips were dysplastic. The question was which path, from surgical correction to careful lifelong medical management, would give this dog the best quality of life over the next 12 or 13 years.
Hip Joint Anatomy and Why Dysplasia Develops
The coxofemoral joint is a ball-and-socket joint in which the rounded femoral head (the ball, at the proximal femur) articulates within the acetabulum (the cup-shaped socket, formed by the fusion of three pelvic bones: the ilium, ischium, and pubis). In a normal hip, the femoral head is spherical and seated deeply within a well-developed acetabulum, with a smooth layer of hyaline cartilage covering both articulating surfaces and a joint capsule and round ligament (ligamentum teres) providing stability. In a dysplastic hip, this congruency is disrupted: the acetabulum may be too shallow (reduced acetabular coverage of the femoral head), the femoral head may be flattened or irregular, and crucially, joint laxity (looseness) during the rapid growth phase of puppyhood allows the femoral head to move excessively within or against the acetabulum during every step. This micro-instability leads to progressive cartilage wear through shearing forces, joint inflammation, joint capsule thickening, periarticular osteophyte (bone spur) formation, and eventually the full articular cartilage loss and subchondral bone sclerosis of end-stage osteoarthritis. Hip dysplasia is both a structural problem (bony incongruity) and a functional problem (joint instability), and both elements must be addressed in treatment planning.
Environmental factors that accelerate hip dysplasia progression in genetically predisposed dogs include: rapid growth rate from high-calorie, high-carbohydrate puppy diets; excess dietary calcium or calcium-to-phosphorus imbalance disrupting endochondral ossification; high-impact repetitive exercise (running on hard surfaces, jumping, rough play) during skeletal growth before 12 to 18 months; and obesity at any age. Conversely, controlled moderate exercise (swimming, leash walking), appropriate body condition, and balanced nutrition support healthier skeletal development in at-risk breeds.
Radiographic Diagnosis and Screening
OFA Extended Hip Radiograph
The OFA (Orthopedic Foundation for Animals) screening radiograph is a ventrodorsal extended view taken with the dog positioned in dorsal recumbency with hips extended and internally rotated (frog-leg position). It is evaluated by three independent board-certified radiologists who assign a consensus grade: Excellent (deep, well-formed acetabula; tightly seated femoral heads), Good, Fair (these three constitute normal and are eligible for OFA registration), Borderline (abnormal but not clearly dysplastic; recheck recommended), or Mild, Moderate, Severe dysplasia. The evaluation requires general anesthesia for proper positioning and is most reliable at 24 months when skeletal maturity is complete, though a preliminary OFA evaluation can be performed as early as 4 months for informational purposes (though preliminary evaluations are not recorded in the OFA database as breeding certifications). One limitation of the OFA extended view is that it is taken with the joint under traction and in a position that reduces apparent laxity; a joint that appears acceptably congruent in extension may still show significant laxity under distraction.
PennHIP Distraction Radiograph and Distraction Index
PennHIP (University of Pennsylvania Hip Improvement Program) uses a specialized technique involving three radiographic views: the compression view (femoral heads pressed fully into acetabula to measure maximum congruency), the distraction view (a distraction device applied between the dog’s legs to apply lateral force and passively subluxate the femoral heads, measuring maximum laxity), and the hip-extended view (similar to OFA). The key measurement is the distraction index (DI): DI = the distance the femoral head center moves from the acetabular center during distraction divided by the femoral head radius. A DI of 0.0 means no subluxation (perfect); a DI of 1.0 means complete dislocation. The DI threshold above which osteoarthritis development is likely varies by breed; in most breeds, a DI greater than 0.3 carries increasing OA risk and a DI above 0.5 or 0.6 is strongly associated with significant OA by mid-life. PennHIP can be reliably performed as early as 16 weeks of age (the earliest evidence of reliable DI), which makes it valuable for early surgical intervention decisions (particularly JPS, which must be performed before 20 weeks). PennHIP results are stored in a database and compared against breed-specific population norms, allowing breeders to select the tightest-hipped individuals within a breed.
Clinical Signs by Disease Stage
| Stage | Age Typical Presentation | Signs | Radiographic Findings |
|---|---|---|---|
| Juvenile laxity phase | 4 to 12 months | Intermittent rear limb lameness; “bunny hopping” gait (both rear limbs move together instead of alternating); reluctance to rise, climb stairs, or jump; positive Ortolani sign on physical exam; pain on hip extension | Joint laxity visible on distraction view; femoral head subluxation; shallow acetabula; minimal or no osteophytes |
| Transitional phase | 12 to 24 months | Lameness may improve as periarticular fibrosis and muscle mass develop, temporarily stabilizing the joint; some dogs appear “better” during this phase; reduced activity level, stiffness after rest, difficulty with prolonged exercise | Early osteophyte formation at femoral neck, acetabular rim; possible flattening of femoral head; joint space may appear reduced |
| Chronic osteoarthritis phase | 2 to 10+ years | Progressive rear limb stiffness and lameness, worse after rest (warming up needed); reduced muscle mass over hindquarters (muscle atrophy from disuse); difficulty rising, reluctance to exercise; altered gait; pain on hip palpation and extension; bilateral cases may present as overall rear end weakness | Significant osteophytosis (bone spurs) at femoral neck and acetabular rim; femoral head remodeling (flattening); subchondral bone sclerosis; reduced joint space; possible subluxation or incongruent joint surfaces |
| End-stage OA | 6 to 14 years | Severe chronic pain; significant loss of range of motion; marked muscle atrophy; dog may be reluctant to bear weight; quality of life significantly affected without adequate pain management | Severe osteophytosis; near-complete loss of articular cartilage (bone-on-bone); remodeled, flattened femoral heads; possibly subluxated or luxated joints |
Physical Examination Tests for Hip Dysplasia
- Ortolani test: The classic test for hip laxity in young dogs; with the dog in lateral recumbency, the examiner places one hand on the greater trochanter and the other stabilizes the pelvis; the hip is adducted (moved toward midline) with the femur held vertically and gentle axial pressure applied (subluxating the femoral head out of the acetabulum); the leg is then slowly abducted (moved away from midline); a positive Ortolani sign is a palpable and sometimes audible “clunk” or “click” as the femoral head reduces back into the acetabulum; the angle at which reduction occurs is the angle of reduction; positive Ortolani indicates significant hip laxity and is most reliable in dogs under 8 to 12 months before periarticular fibrosis reduces apparent laxity
- Barlow test: The reverse of Ortolani; the hip is abducted and the examiner applies adduction with axial loading to subluxate the femoral head; a positive Barlow is a palpable femoral head sliding out of the acetabulum; used together with Ortolani to confirm hip laxity
- Hip extension test: The hip is extended fully while the stifle is held at 90 degrees; pain or discomfort on hip extension is a sensitive (though not specific) sign of hip joint disease; most dysplastic dogs show discomfort, reduced range of motion, or reflexive withdrawal during this test
- Muscle atrophy assessment: Comparison of the semimembranosus, semitendinosus, and biceps femoris muscle bulk bilaterally; chronic hip disease leads to disuse atrophy of the hindquarter musculature; significant asymmetric atrophy suggests a more affected side
Surgical Options for Hip Dysplasia
Juvenile Pubic Symphysiodesis (JPS)
JPS is a preventive procedure for dogs with documented hip laxity on PennHIP at 16 to 20 weeks of age; it is not a treatment for existing dysplasia but a redirection of skeletal growth to improve hip coverage. The pubic symphysis (the cartilaginous joint at the ventral midline of the pelvis) is cauterized electrosurgically, which creates an asymmetric growth arrest: the dorsal pelvis continues growing while ventral growth is arrested, causing the acetabular rim to rotate ventrally over time and increase coverage of the femoral head. The procedure must be performed between 16 and 20 weeks of age (the growth plate window in which pubic symphysis fusion changes pelvic rotation; after 20 weeks the procedure has minimal effect). JPS is a minimally invasive, low-risk procedure with rapid recovery and is the most cost-effective surgical prevention available; it does not require the expensive implants of TPO/DPO. Long-term studies show JPS in dogs with DI above 0.4 significantly reduces OA development compared to untreated controls when performed within the appropriate age window.
Triple Pelvic Osteotomy (TPO) and Double Pelvic Osteotomy (DPO)
TPO/DPO are corrective osteotomies performed in skeletally immature dogs (typically 6 to 10 months) with significant hip laxity and minimal or no existing cartilage damage; the goal is to rotate the acetabular segment to improve femoral head coverage and restore normal joint congruency before OA becomes established. In TPO, the pelvis is cut in three places (ilium, ischium, pubis), and the acetabular segment is rotated by a predetermined angle (typically 20 to 30 degrees) and stabilized with a specialized pelvic plate; DPO uses two cuts (ilium and ischium) and is technically easier with lower morbidity. Patient selection is critical: candidates must have minimal to no radiographic OA, positive Ortolani sign, and be young enough that cartilage remains intact; dogs with moderate to severe pre-existing OA are not candidates because rotating a damaged acetabulum over damaged cartilage does not restore normal function. Post-operative recovery involves strict exercise restriction for 6 to 8 weeks and physical rehabilitation. Success rates (good to excellent function without subsequent OA requiring further intervention) are reported at 85 to 90 percent in well-selected patients.
Femoral Head and Neck Ostectomy (FHO)
FHO removes the femoral head and neck, eliminating the bone-on-bone contact of the dysplastic joint and allowing a fibrous “false joint” (pseudarthrosis) supported by periarticular scar tissue and muscle to form over 3 to 6 months. It is a salvage procedure that eliminates the pain of the dysplastic joint but does not recreate normal joint mechanics. FHO has the best functional outcomes in dogs under 20 to 25 kg (44 to 55 lbs) in which the muscle mass-to-body-weight ratio allows adequate support of the false joint; larger dogs can also have good outcomes but require intensive rehabilitation post-operatively (typically 12 to 16 weeks of aggressive physical therapy including passive range of motion, hydrotherapy, and strengthening exercises to develop the periarticular musculature that supports the false joint). FHO is lower cost ($1,500 to $3,500) than THR and has no implant-related complications, but the functional outcome is generally inferior to a well-placed total hip replacement in larger dogs.
Total Hip Replacement (THR)
THR is the gold standard surgical treatment for hip dysplasia and end-stage hip OA in dogs, providing near-normal joint mechanics and the best long-term functional outcomes for appropriately selected patients. The femoral head and neck are resected and replaced with a femoral stem and head (cobalt-chromium or titanium alloy), and the acetabulum is reamed and replaced with a polyethylene or metal cup; both components are fixed either with polymethylmethacrylate bone cement (cemented THR, faster osseointegration, better suited for geriatric dogs with reduced bone density) or by press-fit with porous surface for biologic bone ingrowth (cementless THR, preferred for younger dogs with good bone density). Dogs weigh a minimum of approximately 15 to 20 kg for the smallest available implant systems, though micro systems exist for smaller dogs. Dogs must have no active infection (hip joint, skin, urinary tract, dental) that could seed the implant with bacteria, adequate bone density for implant fixation, and a compliant owner for the 8 to 12 weeks of post-operative exercise restriction. Complication rates at experienced centers are 5 to 10 percent (luxation, sciatic nerve neurapraxia, implant loosening); 90 to 95 percent of dogs return to normal or near-normal function. Both hips can be replaced, staged 3 to 6 months apart if bilateral disease significantly affects quality of life.
Medical and Rehabilitation Management
NSAIDs for Pain and Inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are the pharmacological foundation of pain management for hip dysplasia-associated osteoarthritis. Veterinary-approved NSAIDs include carprofen (Rimadyl, 4.4 mg/kg/day divided or once daily), meloxicam (Metacam, 0.1 mg/kg/day after 0.2 mg/kg loading dose), deracoxib (Deramaxx, 1 to 2 mg/kg/day), mavacoxib (Trocoxil, monthly dosing, available outside the US), and grapiprant (Galliprant, 2 mg/kg/day), which works through a novel EP4 prostaglandin receptor antagonist mechanism rather than COX inhibition, offering a potentially favorable GI and renal safety profile. Baseline bloodwork (CBC, chemistry) should be obtained before starting chronic NSAID therapy, and monitoring every 6 to 12 months is recommended for dogs on long-term NSAIDs. NSAIDs should never be combined with each other or with corticosteroids (GI ulceration risk). A washout period of 5 to 7 days is required when switching between NSAIDs or transitioning to corticosteroids.
Multimodal Pain Management
- Gabapentin: 5 to 10 mg/kg orally 2 to 3 times daily; addresses neuropathic and central sensitization pain components that NSAIDs alone may not adequately control in chronic OA; sedation is the primary side effect, usually transient; useful adjunct to NSAIDs for moderate to severe chronic pain
- Amantadine: 3 to 5 mg/kg/day orally; NMDA receptor antagonist that reduces central wind-up and sensitization in chronic pain states; effective adjunct for dogs with chronic OA pain no longer adequately controlled by NSAIDs alone; study by Lascelles et al. (2008) demonstrated improved pain scores in dogs with OA when amantadine was added to meloxicam vs. meloxicam alone
- Polysulfated glycosaminoglycan (Adequan): Injectable DMOA; 2 mg/kg IM twice weekly for 4 weeks, then monthly maintenance; inhibits cartilage-degrading enzymes, stimulates hyaluronic acid production, provides cartilage matrix substrate; most evidence-based injectable disease-modifying option available; often initiated at diagnosis and continued long-term
- Omega-3 fatty acids (EPA and DHA from fish oil): Anti-inflammatory effects through competitive inhibition of arachidonic acid metabolism; a dose of 50 to 75 mg/kg/day combined EPA+DHA has demonstrated clinical benefit in OA pain scores and reduced NSAID requirements in controlled studies in dogs; high-quality triglyceride-form fish oil (not ethyl ester form) is preferred for bioavailability
- Anti-NGF therapy (frunevetmab/Librela): Monoclonal antibody targeting nerve growth factor (NGF), a key pain signaling molecule in OA; Librela (frunevetmab, licensed in the EU and US for canine OA pain) is given as a monthly subcutaneous injection; clinical studies show significant reduction in pain and improved mobility scores; an additional therapeutic option alongside or instead of NSAIDs for dogs with NSAID intolerance or inadequate response
- Intra-articular injections: Corticosteroids (methylprednisolone acetate) provide temporary anti-inflammatory relief (typically 4 to 12 weeks) but repeated injections accelerate cartilage degradation and are used sparingly; hyaluronic acid injections have variable evidence; platelet-rich plasma (PRP) and stem cell therapy (adipose-derived mesenchymal stem cells) are available through specialty practices with emerging evidence of benefit but less robust clinical trial data than conventional treatments
Physical Rehabilitation
Certified canine rehabilitation practitioners (CCRP or CCRT certification) offer structured physical therapy that is increasingly recognized as an essential component of hip dysplasia management, both post-surgically and as long-term management for non-surgical cases. Key modalities include: underwater treadmill hydrotherapy (the buoyancy of water reduces joint loading while the resistance builds muscle strength; one of the most effective tools for building hindquarter muscle mass without high-impact stress), therapeutic exercises (sit-to-stand repetitions, cavaletti rails, balance boards, supported walking exercises), therapeutic laser (Class IV laser therapy; reduces pain and inflammation through photobiomodulation; typically applied 2 to 3 times per week), manual therapy and massage, and acupuncture. A 2019 study by Mlacnik et al. demonstrated that physical rehabilitation combined with weight loss produced greater improvement in hip OA pain scores than either intervention alone. Referral to a canine rehabilitation practitioner is appropriate for any dog with hip dysplasia, regardless of whether surgery is planned.
Breed Predispositions to Hip Dysplasia
| Breed | OFA Hip Dysplasia Rate (approximate) | Notes |
|---|---|---|
| Bulldog (English) | 73% | Highest OFA-reported rate of any breed; brachycephalic conformation affects pelvic anatomy |
| Pug | 64% | Conformation-related; hind limb weakness often multifactorial (also spinal issues) |
| Dogue de Bordeaux | 57% | Giant/heavy breed; rapid growth amplifies laxity |
| Neapolitan Mastiff | 54% | Rapid growth, extreme body weight |
| Saint Bernard | 49% | Giant breed; historically high rates; active OFA screening programs |
| German Shepherd Dog | 19% | Most commonly diagnosed breed in absolute numbers due to population size; improved from 50%+ in 1970s through OFA screening programs |
| Golden Retriever | 20% | Improved through OFA/PennHIP screening; still a significant concern in the breed |
| Labrador Retriever | 12% | Most popular US breed; OFA screening widely practiced; obesity strongly amplifies risk |
| Rottweiler | 20% | Also predisposed to osteosarcoma of distal femur; dysplastic hips are a separate concurrent concern |
| Bernese Mountain Dog | 24% | Multiple concurrent orthopedic disease risks (also elbow dysplasia, cruciate disease) |
| Great Dane | 13% | Giant breed; lean body condition at all times is especially critical |
| Irish Wolfhound | 13% | Rapid growth rate; also predisposed to portosystemic shunts and dilated cardiomyopathy |
Age-Specific Considerations
Puppies (Under 6 Months)
- This is the window for preventive intervention; any large or giant breed puppy showing rear limb weakness, bunny-hopping gait, or reluctance to exercise should have hip palpation at the 4-month wellness visit; a positive Ortolani sign in a 4-month-old puppy warrants PennHIP radiographs under sedation; JPS must be performed before 20 weeks to utilize the pelvic growth redirection window; it is low-risk, low-cost, and the most accessible surgical prevention available
- Nutritional management in this window is critical: large and giant breed puppies should be fed a diet formulated for large breed growth (controlled calorie density, correct calcium-to-phosphorus ratio of approximately 1.2:1 to 1.4:1); avoid supplemental calcium (disrupts endochondral ossification); avoid free-choice feeding (controlled portions prevent rapid weight gain); keep body condition score at 4 to 5 out of 9 throughout growth
- Exercise: avoid repetitive high-impact activities (jumping, running on hard surfaces, rough play with larger dogs) before 12 to 18 months; swimming is an excellent low-impact exercise that builds hindquarter muscle without joint loading; leash walks on grass or softer surfaces are appropriate
Young Adults (6 Months to 3 Years)
- This is the window for corrective osteotomy (TPO/DPO) in dogs with confirmed hip laxity and minimal OA; the ideal candidate is 6 to 12 months old, has a positive Ortolani sign, no or minimal radiographic OA, and body weight appropriate for their frame; consult a board-certified veterinary surgeon (DACVS) for assessment before this window closes; dogs over 12 to 18 months with established OA are generally no longer candidates for osteotomy and medical management or eventual THR becomes the path
- Dogs in the transitional phase (12 to 24 months) may appear clinically improved as periarticular fibrosis develops; do not interpret clinical improvement as resolution; radiographic disease continues to progress and baseline hip radiographs for comparison should be obtained during this period
- Initiate Adequan (polysulfated glycosaminoglycan) injections at diagnosis regardless of whether surgery is planned; early disease-modifying therapy slows OA progression; combine with fish oil supplementation and strict weight management
Middle-Aged and Senior Dogs (3 Years and Older)
- Chronic OA management is the primary focus; multimodal pain management (NSAID plus gabapentin plus Adequan maintenance plus fish oil) provides the most consistent relief; monitor renal and hepatic function twice yearly with bloodwork for any dog on long-term NSAIDs; if NSAID response is inadequate, add amantadine or transition to frunevetmab (Librela) as an NSAID alternative or adjunct
- Total hip replacement remains available for dogs of any age with adequate bone quality and no concurrent serious disease; age is not a contraindication to THR; a 9-year-old dog with a 4-year life expectancy who is no longer comfortable on medical management can still benefit meaningfully from THR; the decision requires assessing anesthetic risk, bone quality, and quality-of-life impact
- Weight management becomes even more critical as activity level decreases with age; many dysplastic dogs gain weight as they exercise less due to pain, and the increased joint loading from obesity further worsens pain and progression; a structured weight loss plan supervised by the veterinarian (target body condition score 4 to 5 out of 9) and transition to a lower-calorie maintenance diet often provides meaningful clinical improvement
US Cost Overview for Hip Dysplasia Diagnosis and Treatment
| Item | Typical US Cost |
|---|---|
| OFA hip radiograph (24 months, includes OFA evaluation fee) | $200 to $400 |
| PennHIP radiographs (sedation required, includes DI calculation) | $300 to $500 |
| Juvenile pubic symphysiodesis (JPS) | $400 to $1,000 |
| Triple/double pelvic osteotomy (TPO/DPO, per hip) | $2,500 to $5,000 per hip |
| Femoral head and neck ostectomy (FHO, per hip) | $1,500 to $3,500 per hip |
| Total hip replacement (THR, per hip) | $4,500 to $8,000 per hip |
| Adequan (polysulfated glycosaminoglycan) induction course | $100 to $200 (8 injections) |
| Adequan monthly maintenance injection | $25 to $50 per injection (owner-administered) |
| Librela (frunevetmab) monthly injection | $80 to $150 per injection |
| Physical rehabilitation consultation (initial) | $75 to $150 |
| Underwater treadmill session | $50 to $100 per session |
| Chronic NSAID therapy (generic carprofen) per month | $20 to $60/month depending on dog size |
Myths and Facts About Dog Hip Dysplasia
If my dog is not limping, the hip dysplasia is not serious or does not need treatment.
Dogs are remarkably stoic and often do not limp visibly until osteoarthritis is moderate to severe and both hips are affected equally (bilateral disease masks lameness because there is no single better limb to favor). A dog with bilateral hip dysplasia and significant OA may appear to move relatively symmetrically despite being in constant pain; the signs owners more often notice are reduced enthusiasm for activity, difficulty rising, stiffness after rest, reluctance to jump into cars or onto furniture, and behavioral changes (irritability, reduced interaction) from chronic pain. Radiographic hip disease often significantly outpaces the clinical signs the owner observes. A dog that “seems fine” on moderately dysplastic hips may be managing a significant pain burden that is robbing it of quality of life. Regular veterinary assessment and monitoring of mobility, muscle mass, and pain response guides treatment decisions better than waiting for obvious limping.
Hip dysplasia surgery removes the need for any further treatment for life.
No surgery for hip dysplasia eliminates the need for ongoing management. TPO/DPO redirects joint development and significantly reduces OA progression but does not guarantee a lifetime free of joint disease; these dogs still benefit from weight management, appropriate exercise, and periodic monitoring. FHO creates a functional but biomechanically abnormal joint that requires lifelong muscle conditioning and may develop some discomfort in later years, particularly in larger dogs. Even total hip replacement, the most definitive option, requires lifelong exercise restriction (no jumping, no running off-leash, no high-impact activities), post-operative physical rehabilitation, and monitoring for implant loosening or wear over 8 to 12 years. The contralateral hip also continues to age; dogs who have one THR often eventually need a second for the other hip if both were dysplastic. Surgery changes the trajectory of the disease; it does not end the veterinary relationship with the hip.
Hip dysplasia only affects large breeds; small dogs do not get it.
While hip dysplasia is significantly more common in large and giant breeds and carries greater clinical impact due to body weight, it does occur in small breeds. English Bulldogs, Pugs, and French Bulldogs have some of the highest OFA-reported hip dysplasia rates of any breed despite being small to medium in size, driven by their conformation. Miniature and Toy Poodles, Dachshunds, and Cocker Spaniels are also reported to have hip dysplasia at meaningful rates. Small dogs often compensate better due to lower joint loading forces from lower body weight, and many small dysplastic dogs are managed well with weight control and NSAIDs without surgery. FHO has excellent functional outcomes in small dogs regardless of the cause of hip disease.
Red Flags: Signs That Mean See a Vet Soon
- A puppy of a predisposed large breed (German Shepherd, Golden Retriever, Lab, Rottweiler, Saint Bernard) showing bunny-hopping gait, reluctance to rise, or rear limb weakness before 12 months: schedule an orthopedic evaluation and PennHIP screening; the JPS window closes at 20 weeks and the TPO/DPO window closes around 10 to 12 months
- Sudden complete non-weight-bearing on a rear limb in a dog with known hip dysplasia: acute luxation (the femoral head has dislocated completely from the acetabulum) or acute cruciate ligament rupture (a concurrent injury in dogs with abnormal hind limb biomechanics); emergency evaluation needed; closed reduction under anesthesia within 24 to 72 hours of acute luxation is necessary before soft tissue swelling prevents reduction
- Progressive rear limb weakness, “drunken sailor” gait, or apparent loss of proprioception (knuckling, stumbling, dragging toes) combined with apparent spinal pain: not all rear weakness in large breed dogs is hip dysplasia; degenerative myelopathy (DM, a progressive spinal cord disease common in German Shepherd Dogs, Pembroke Welsh Corgis, Boxers, and Chesapeake Bay Retrievers) or lumbosacral stenosis can produce similar signs and must be distinguished from hip OA by neurological examination and advanced imaging (MRI)
- A dog on long-term NSAIDs developing vomiting, dark or tarry stools, reduced appetite, or increased thirst and urination: GI ulceration or NSAID-induced nephrotoxicity; discontinue the NSAID and schedule a veterinary evaluation with bloodwork; do not restart NSAIDs without renal function assessment
- Any dog post-hip surgery showing acute lameness, swelling at the surgical site, fever, or discharge: possible surgical site infection or implant complication; contact the surgical team immediately
Frequently Asked Questions About Dog Hip Dysplasia
At what age does hip dysplasia show up in dogs?
Hip dysplasia is a developmental disease, meaning the abnormality is present from birth (or develops during early growth) but clinical signs vary by individual. Some puppies show signs as early as 4 to 6 months: rear limb lameness, bunny-hopping gait, difficulty rising, and reluctance to exercise. Others show no obvious signs during puppyhood, then develop progressive osteoarthritis-related stiffness and lameness in middle age (2 to 5 years) or later. The timing of symptom onset depends on the severity of the joint laxity, the dog’s body weight and condition, activity level, and whether the other hip is also affected. A dog can have significant radiographic hip dysplasia with minimal clinical signs, or mild radiographic disease with significant pain, because individual pain sensitivity and compensation vary considerably.
Can hip dysplasia be cured?
Hip dysplasia as a structural abnormality cannot be completely cured, but it can be managed very effectively. JPS and TPO/DPO performed at the right age in the right patient significantly improve joint geometry and reduce or prevent OA progression; dogs treated with pelvic osteotomy at a young age often have near-normal function throughout their lives with appropriate management. Total hip replacement functionally recreates a near-normal joint and gives excellent long-term outcomes. For dogs managed medically, while the underlying joint abnormality and OA progression continue, multimodal pain management, weight control, and physical rehabilitation can provide very good quality of life for many years. “Cured” is not the right frame; “well managed” and “comfortable with good function” is what successful hip dysplasia treatment achieves.
What is the best surgery for hip dysplasia in dogs?
The best surgery depends on the dog’s age, severity of disease, body weight, owner resources, and the surgeon’s assessment. For puppies under 20 weeks with confirmed laxity on PennHIP, JPS is the most accessible and cost-effective preventive option. For dogs 6 to 12 months with significant laxity and minimal OA, TPO or DPO (performed by a board-certified veterinary surgeon) offers excellent long-term outcomes. For dogs with established OA where osteotomy is no longer appropriate, THR is the best functional outcome for dogs over approximately 15 to 20 kg; FHO is appropriate for smaller dogs or as a salvage option. No single surgery is universally “best”; the right choice requires a consultation with a board-certified veterinary surgeon who can assess the specific patient’s imaging and clinical presentation.
How can I help my dog with hip dysplasia at home?
Several evidence-based home management strategies make a meaningful difference: maintain strict lean body weight (body condition score 4 to 5 out of 9; this is the single most impactful thing you can do); provide low-impact regular exercise (leash walks on soft surfaces, swimming) rather than sporadic high-intensity activity; provide orthopedic memory foam bedding that cushions joints during rest; place food and water bowls at a raised height to reduce the need to crouch; use ramps rather than stairs for getting into cars or onto furniture; give fish oil at an evidence-based dose (50 to 75 mg/kg/day of combined EPA+DHA); administer Adequan injections per your veterinarian’s protocol; and ensure the dog’s prescribed NSAIDs are given consistently with food rather than only on visibly painful days (consistent blood levels provide better pain control than as-needed dosing for chronic OA).
Is hip dysplasia painful for dogs?
Yes. Hip dysplasia causes chronic pain from the moment of joint instability and cartilage wear. The degree of pain varies with disease stage, body weight, activity level, and individual pain sensitivity. Pain comes from multiple sources: synovial inflammation from cartilage breakdown products, joint capsule stretch from laxity, periosteal pain from osteophyte formation, and, in advanced disease, subchondral bone exposure with bone-on-bone contact. Dogs often do not visibly vocalize or limp until pain is significant; behavioral signs (reduced play, difficulty rising, irritability, reluctance to be touched around the hips) are earlier indicators. Chronic unmanaged pain in hip dysplasia is associated with muscle atrophy, reduced overall activity, obesity (from reduced movement), and diminished quality of life. Effective pain management throughout the disease course is not optional; it is central to maintaining the dog’s wellbeing.
Can I breed a dog with hip dysplasia?
No responsible breeding organization recommends breeding dogs with confirmed hip dysplasia. OFA recommends only breeding dogs with Excellent, Good, or Fair hip grades; dogs graded Borderline, Mild, Moderate, or Severe should not be bred. PennHIP recommends selecting breeding animals from within the tightest 50th percentile of distraction index for their breed (the lower the DI, the tighter the hips), with the goal of shifting the breed population toward tighter hips over generations. Breeding a dysplastic dog, even a mild case, contributes the predisposing alleles to the next generation. The significant progress made in reducing severe hip dysplasia rates in German Shepherd Dogs and Labrador Retrievers over the past 40 years was achieved almost entirely through consistent OFA/PennHIP screening and selective breeding; undermining that progress by breeding affected individuals has real, multigenerational consequences for the breed.
What is the difference between OFA and PennHIP screening?
OFA (Orthopedic Foundation for Animals) uses a ventrodorsal extended hip radiograph to assess joint congruency and assigns a categorical grade (Excellent through Severe); it requires 24 months of age for a permanent certification. PennHIP (University of Pennsylvania Hip Improvement Program) measures passive hip laxity using a distraction radiograph and calculates a distraction index (DI), which is a continuous measurement of joint laxity; it can be performed as early as 16 weeks. PennHIP is considered more sensitive for detecting hip laxity that predicts OA, allows earlier intervention decisions, and enables comparison against breed-population norms. OFA is more widely used, less expensive, and the standard for most breed club health certifications. Both programs require a certified practitioner: PennHIP requires a PennHIP-certified veterinarian to perform the procedure; OFA accepts radiographs from any veterinarian submitted to their database for evaluation.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles